期刊文献+

高效液相色谱-荧光法测定人血浆替米沙坦浓度 被引量:3

Determination of telmisartan concentration in human plasma by HPLC-FLU method
下载PDF
导出
摘要 目的:建立血浆中替米沙坦浓度的高效液相色谱分析方法。方法:采用高效液相色谱荧光法,对流动相的组成进行了考察,确定乙腈水醋酸三乙胺(60∶40∶0.4∶0.3,pH4.2)为流动相洗脱;流速:1mL·min-1,激发波长:295nm,发射波长:385nm。内标法定量,血浆样品经简单的预处理后进样,血浆中内源性物质不干扰替米沙坦的测定。结果:替米沙坦在2.5~120.0μg·L-1范围内线性关系良好(r=0.9994),最低检测限为1.25μg·L-1;低、中、高3种浓度样品的平均方法回收率分别为98.02%,102.13%,100.57%;精密度分别为4.06%,6.17%,2.38%。结论:本方法准确、快速、简便、灵敏度高,适合替米沙坦的药动学的研究。 OBJECTIVE To establish an analytical method for determination of telmisartan in human plasma. METHODS HPLCFLU method was applied to measure telmisartan concentration. The mobile phase composition was selected to get a good separation and peak shape. Finally, the elute solution was prepared as follow: acetonitrile-water- acetic acid-triethylamine(60:40:0. 4:0. 3; pH 4. 2) ; the flow rate was 1 mL·min^-1. The excitation and emission wavelength was 295 nm and 385 nm, respectively. Internal standard method quantified telmisartan concentration in plasma. Prior to analysis, the plasma sample was pretreated easily through onestep extraction. No intrinsic substances interfered analysis of telmisartan. RESULTS A good linear relationship was observed from 2. 5-120. 0μg·L^-1 , the detection limit was 1.25μg·L^-1. The relative recovery rate of three concentration samples were 98. 02%, 102. 13%,100. 57%; and the precise were 4. 06%,6. 17%,2.38%,respectively. CONCLUSION The method is accurate, simple, rapid and sensitive; it can be used for the pharmacokinetics research of telmisartan.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2005年第8期715-717,共3页 Chinese Journal of Hospital Pharmacy
关键词 高效液相色谱法 替米沙坦 血药浓度 HPLC telmisartan plasma drug concentration
  • 相关文献

参考文献4

  • 1Torrealday N,Gonzalez L,Alonso RM,et al. Experimental design approach for the optimization of a HPLC-fluorimetric method for the quantitation of the angiotensin Ⅱ receptor antagonist telmisartan in urine[J]. J Pharm Biomed Anal,2003 Aug, 32(4-5) :847~857.
  • 2丁雪琴,晁若冰,廖靓,李国川.HPLC测定替米沙坦的含量和有关物质[J].华西药学杂志,2003,18(3):212-214. 被引量:11
  • 3赵霞,许俊羽,刘文英.反相高效液相色谱法测定大鼠血浆中替米沙坦的浓度[J].中国药科大学学报,2003,34(3):247-249. 被引量:21
  • 4J Stangier, CA Su, A Fraunhofer, et al. Pharmacokinetics of acetaminophen and ibuprofen when coadministered with telmisartan in healthy volunteers[J]. J Clin Pharmacol,2000,40(12):1338~1346.

二级参考文献7

  • 1[1]Ries UJ, Mihm G, Narr B, et al. 6-substituded Benzimid azoles as New Nonpeptide Angiotensin Ⅱ Receptor Antagonists: Synthesis, Biologi cal Activity, and structure-Activity Relationship[J]. J med chem.1993,(36): 4040
  • 2[2]Dina R, Jafari M. Angiotensin Ⅱ-receptor antagonists: An overview[J]. Am J Health-Syst Pharm, 2000,(57): 1231
  • 3Wienen W, Hauel N,Van meel JCA, et al. Pharmacological characterization of the novel nonpeptide angiotension Ⅱ receptor antagonist,BIBR-277[J]. Br J Pharmacol,1993,110:245-252.
  • 4Stangier J, Schmid J,Turk D, et al. Absorption,metabolish andexcret-Ion of int-ravenously and orally administered [ C14 ] telmisartan in healthy volunteers [J]. J Clin Pharmacol, 2000,40:1338-1346.
  • 5Mcclellan KJ, Markham A. Telmisartan[J]. Drugs, 1998,56(6):1039-1044.
  • 6Stangiet J,Su CA, Hendriks MGC, et al.The effect of telmisartan on the steady state pharmcokinetics of digoxin in healthy male volunteers[J]. J Clin Pharmacol ,2000,40(121) : 1373-1379.
  • 7孙忠实.新型AT拮抗剂──替米沙坦[J].中国新药杂志,1999,8(12):801-802. 被引量:24

共引文献28

同被引文献19

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部